Clinical Trials in Nashville

Showing 7481-7500 of 15,379 trials

WITHDRAWN< 1 mile

Prostaglandin E2 as a Critical Mediator of Sex Disparities in Asthma

NCT03825302

This study seeks to understand how biological sex influences airway hyperresponsiveness in adult asthma.

Asthma

Vanderbilt University Medical CenterStarted Dec 2021

Nashville, Tennessee, United States

COMPLETEDPhase 1< 1 mile

Study of FCN-437c in Patients With Advanced Solid Tumors

NCT03951116

This research study is studying a drug called FCN-437c as a possible treatment for patients with advanced unresectable/metastatic solid tumors.

Solid Tumor, Adult

Fochon Pharmaceuticals, Ltd.22 participantsStarted Jun 2019

Duarte, California, United States • Nashville, Tennessee, United States • San Antonio, Texas, United States

COMPLETEDPhase 3< 1 mile

Phase 3b Safety and Efficacy Study of Apremilast to Treat Moderate to Severe Plaque-plaque Psoriasis

NCT01690299

This study will test the clinical effectiveness and safety of apremilast compared with placebo as well as etanercept compared with placebo in the same group of patients with moderate to severe plaque psoriasis.

PsoriasisPsoriatic Arthritis

Amgen250 participantsStarted Oct 2012

Phoenix, Arizona, United States • Bakersfield, California, United States • Irvine, California, United States +79 more locations

Prostaglandin E2 as a Critical Mediator of Sex Disparities in Asthma

Study of FCN-437c in Patients With Advanced Solid Tumors

Phase 3b Safety and Efficacy Study of Apremilast to Treat Moderate to Severe Plaque-plaque Psoriasis

Find Trials by Condition in Nashville

Sensory Symptoms in Tourette Syndrome and Obsessive-Compulsive Disorder

A Study of Bermekimab in Patients With Hidradenitis Suppurativa

Gravity- Versus Suction-driven Large Volume Thoracentesis

Adaptive COVID-19 Treatment Trial (ACTT)

Cholinesterase Activity and DeliriUm During Critical Illness Study

HTX-011 Administration Study in Planned Caesarean Section Procedure

Study of BOS161721 in Systemic Lupus Erythematosus (SLE) Patients on a Background of Limited Standard of Care

A Study of GSK1349572 Versus Raltegravir (RAL) With Investigator Selected Background Regimen in Antiretroviral-Experienced, Integrase Inhibitor-Naive Adults

Safety and Efficacy of Isatuximab in Lymphoblastic Leukemia

Study to Evaluate Safety and Effectiveness of Oral Apremilast (CC-10004) in Patients With Moderate to Severe Plaque Psoriasis.

CALERIE: Comprehensive Assessment of Long-Term Effects of Reducing Intake of Energy

Blood Culture Improvement Guidelines and Diagnostic Stewardship for Antibiotic Reduction in Critically Ill Children

A Study to Assess the Impact of Omalizumab on Exercise Capacity, Physical Activity, and Sleep Quality in Participants With Moderate to Severe Allergic Asthma

Next Generation Sequencing Versus Traditional Cultures for Clinically Infected Penile Implants: Impact of Culture Identification on Outcomes

A Safety Study of LY3462817 and LY3509754 in Participants With Psoriasis

Phase 1, Dose-Escalation Study of IGN002 in NHL Subjects

A Phase 3 Open Label Extension Study of Fostamatinib Disodium in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia